RE:RE:RE:RE:Anyone have guess on where we go from here?I can't remember where exactly but I did read that Berendt does have a back up plan. I hope he unveils this sooner rather than later.
I was able to listen today but did read the uopdates, it seemed like the committee for the most part were looking for reasons not approve rather than what it did do for the patients involved in the study and the good it could do.
There was also a comment by one of the members stating that "we can't approve all the drugs" This was a disappointing comment since each should be reviewed without consideration on how many have been approved.
The other part of this is why would Ipsen, analysts and several subject matter experts back this drug if there was not potential.
Very disappointed and will take a break from looking at this for a while, tomorrow may be ugly sp again I hope Bernedt has something prepared to calm the situation.